Canada's Drug Agency now recommends that public drug plans cover lecanemab for early Alzheimer's, reversing the no it issued back in February. If someone in your family is living with early memory loss, that shift in lecanemab coverage could open a door that felt firmly shut a season ago. This is what changed, who qualifies, and what to ask your doctor.
The drug is lecanemab, sold as Leqembi. It is an antibody, a lab-made protein built to latch onto one target, and here that target is amyloid plaque, the sticky buildup in the brain that many researchers see as a driver of Alzheimer's. Health Canada approved it last October, but approval and payment are separate hurdles in this country.
What actually changed in the decision?
In February, the agency recommended against paying for lecanemab, citing unclear real-world benefit and possible side effects like brain swelling or small bleeds. In mid-July, after the maker, Eisai, supplied longer-term data and asked for a second look, the committee reversed itself. It decided it had underestimated the benefit for people with early Alzheimer's disease, who have few options and a condition that only moves one way.
Why would the experts change their minds?
Two things shifted. Alzheimer societies pushed hard, arguing the drug stretches out the milder stage, more time recognizing faces and running your own day. And the safety worry gained context: the swelling or tiny bleeds seen with this kind of disease-modifying treatment, one that targets the disease itself rather than just easing symptoms, are usually mild and often show up only on an MRI. Cost matters too. At about $32,000 a year, paying out of pocket is off the table for most families.
Who actually qualifies for coverage?
The recommendation carries firm conditions. To be eligible for lecanemab coverage, a person must be in the early window, either mild cognitive impairment (noticeable memory changes that do not yet derail daily life) or mild dementia due to Alzheimer's. Amyloid must be confirmed by a brain scan or spinal fluid test, and regular MRIs catch swelling early. One line matters most: if the disease reaches the moderate stage, coverage stops, because the benefit only holds early.
How do you take the next step if memory changes worry you?
Because the drug only helps early, early diagnosis matters more than ever. If you have been shrugging off memory slips, get assessed sooner rather than later, and a family doctor can run first checks and refer you onward. Our 10-minute memory test guide sorts ordinary aging from what is worth flagging, and the aging symptoms that are not actually normal is a good gut check. If the trouble feels more like fog and burnout, that guide may fit better.
Frequently asked questions
What is lecanemab coverage and who decides it?
Lecanemab coverage means whether public drug plans will pay for the drug. Canada's Drug Agency now recommends it with conditions, but the advice is non-binding. Each province and territory decides for itself, and a national body still has to negotiate a lower price, so timing will vary by region.
Is lecanemab a cure for Alzheimer's?
No. Lecanemab does not cure Alzheimer's or restore lost memory. In trials it slowed the slide from mild symptoms toward serious dementia by roughly five to seven months. For many families that means more independent time, but it is a delay in progression, not a reset.
What are the main risks of the drug?
The main risks are brain swelling and small bleeds. Experts say these are usually mild and often cause no symptoms, turning up only on the MRIs that monitoring requires. Anyone considering the drug should weigh the benefits and risks with their own healthcare team.
Where to go from here
If memory changes have been on your mind, you do not have to sit with the worry alone. You can find and book a doctor near you on Medimap and start the conversation this week, or browse the Health Hub for more brain-health guides.
This article is general information, not medical advice, and Medimap is not a substitute for your doctor. For a medical emergency, call 911. For non-urgent concerns, see a licensed health professional.
Find an allergy or specialist clinic near you? Search through Medimap — no referral needed.
Search clinics →